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Context
Feline calicivirus (FCV) causes a variable syndrome of 
upper respiratory tract disease, mouth ulcers and lameness. 
It is associated with lymphoplasmacytic gingivitis stoma-
titis complex (LGSC) and as an RNA virus, FCV evolves 
quickly and is extremely diverse. This is seen in phyloge-
netic analyses of genomic sequence data, which typically 
result in a ‘star-like’ phylogeny with many strains cocir-
culating. This FCV strain diversity is a major challenge 
for vaccine cross-protection, with vaccine antigens chosen 
to be broadly cross-reactive. Attempts to identify robust 
groupings of FCV either on temporal, clinical or spatial 
grounds have largely failed. This is in contrast to the related 
calicivirus causing gastroenteritis in people (human noro-
virus), where a major strain variant circulates internation-
ally. However, there have been no attempts to analyse the 
international diversity of FCV. This study aims to describe 
the diversity of FCV in a population of cats attending vet-
erinary practices chosen by convenience in five European 
countries.
Main conclusion
The strain diversity of FCV was confirmed in five 
European countries. Although strains persist and circulate 
locally there was no evidence for widescale national or 
international dispersal of individual strains.
Approach
A convenience-based prospective cohort of cats was 
recruited by veterinary surgeons in 13 sites in five 
countries in Europe (five sites in France, all in the Paris 
area), two in the UK (Bangor in Northern Ireland and 
Northampton), two in Portugal (Mem Martins and 
Lisbon area), one in Greece (Thessaloniki), and three sites 
in Germany (Lippstadt, Berlin and Achim). Individual 
cats were recruited either through attending the veteri-
nary clinic, or when a veterinary surgeon from the clinic 
visited a local cat shelter.
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FIG 1: Unrooted Kimura 2-parameter Neighbour joining 
tree of partial capsid sequences from this study and FCV 
vaccine strain F9. Each sequence has a unique ID made 
up of a country code (FRance, GErmany GReece, 
PorTugal and United Kingdom) and site number (1 to 5)_
sample number. Strains represented by more than a 
single sequence (less than 20 per cent divergence) are 
boxed, additionally labelled A-N and the intra-strain 
capsid diversity indicated in the box. Where multiple 
sequences came from a single household they are 
indicated by an additional symbol (○, o, Δ, *, ). The 
percentage of replicate trees in which the associated 
taxa clustered together in bootstrap tests (1000 
replicates) is shown next to the branches (only bootstrap 
values greater than 75 per cent are shown). Distances 
are drawn to scale and relate to the distance bar.
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From each cat, an oropharyngeal swab and a question-
naire completed by the owner were collected. Diagnosis 
of FCV and feline herpesvirus type 1 (FeHV-1) was deter-
mined by virus isolation. Risk factors potentially associ-
ated with FCV infection were assessed by multivariable 
analyses. Sequence and phylogenetic analyses of capsid 
and polymerase sequences were used to analyse strain 
diversity, evolution and transmission between countries.
Results
A total of 426 samples were collected. For 17 samples, the 
viral status could not be assessed due to bacterial overgrowth. 
For the remaining 409, FCV and FeHV-1 were isolated from 
91 (22.2 per cent) and 18 (4.4 per cent) cats, respectively. For 
FCV, 16.2 per cent of healthy cats and 34.2 per cent of sick 
(at least one clinical sign) cats tested positive. For FeHV-1, 
the figures were 2.6 and 8.0 per cent. Multivariable analy-
sis found that animals presenting with LGSC were 9.33 (95 
per cent confidence interval 3.18 to 29.45) times more likely 
to present with FCV infection than cats without LGSC. 
Furthermore, vaccinated cats up to 48 months old were sig-
nificantly less likely to be infected with FCV than unvac-
cinated animals of similar ages.
Phylogenetic analysis based on consensus sequences for 
the immunodominant region of the capsid gene from 72 
FCV isolates identified 46 strains (pairwise genetic distance 
greater than 20 per cent) (fig1). There was no evidence of 
widescale clustering at the geographical level; rather strains 
from each country were dispersed throughout the tree. 
Thirteen of the 14 strains with more than one sequence 
were restricted to individual regions or sites in individual 
countries with the exception being a strain present in two 
sites close to each other in France. Four strains were present 
in more than one household. Five colonies (four of which 
were rescue shelters) had multiple strains within them. 
Polymerase sequences suggested possible rare recombina-
tion events.
Interpretation
The study confirms the close association between FCV 
and LGSC, and provides evidence for a protective effect 
of FCV vaccination against infection in young cats. 
Phylogenetic analyses point to a range of transmission 
dynamics and reaffirm the role of multicat households and 
shelters as potential generators of strain diversity. These 
locally, nationally and internationally diverse FCV popu-
lations maintain a continuous challenge to the control of 
FCV infection and disease. This was a ‘convenience’ sam-
ple of cats and FCV isolates, so may not be completely rep-
resentative of the general population.
Significance of findings
High levels of strain diversity point to the continued rapid 
evolution of FCV. A lack of dominant circulating strains 
reaffirms the need to choose vaccine antigens on their abil-
ity to be broadly cross-reactive.
